Logo image of RBCN

RUBICON TECHNOLOGY INC (RBCN) Stock Fundamental Analysis

NASDAQ:RBCN - Nasdaq - US78112T2069 - Common Stock - Currency: USD

1.3  -0.02 (-1.52%)

After market: 1.3 0 (0%)

Fundamental Rating

2

Overall RBCN gets a fundamental rating of 2 out of 10. We evaluated RBCN against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. RBCN may be in some trouble as it scores bad on both profitability and health. RBCN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

RBCN had positive earnings in the past year.
In the past year RBCN has reported a negative cash flow from operations.
RBCN Yearly Net Income VS EBIT VS OCF VS FCFRBCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -20M -40M -60M

1.2 Ratios

The Return On Assets of RBCN (15.17%) is better than 75.47% of its industry peers.
With a decent Return On Equity value of 26.97%, RBCN is doing good in the industry, outperforming 79.25% of the companies in the same industry.
Industry RankSector Rank
ROA 15.17%
ROE 26.97%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RBCN Yearly ROA, ROE, ROICRBCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -20 -40 -60 -80 -100

1.3 Margins

RBCN has a better Profit Margin (20.86%) than 74.53% of its industry peers.
RBCN does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 20.86%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RBCN Yearly Profit, Operating, Gross MarginsRBCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 -100 -200 -300

More info and screens

3

2. Health

2.1 Basic Checks

RBCN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RBCN has been increased compared to 1 year ago.
RBCN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RBCN Yearly Shares OutstandingRBCN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 500K 1M 1.5M 2M 2.5M
RBCN Yearly Total Debt VS Total AssetsRBCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -85.40, we must say that RBCN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -85.40, RBCN is not doing good in the industry: 89.62% of the companies in the same industry are doing better.
RBCN has a Debt/Equity ratio of 0.52. This is a neutral value indicating RBCN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.52, RBCN is doing worse than 72.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z -85.4
ROIC/WACCN/A
WACC11.23%
RBCN Yearly LT Debt VS Equity VS FCFRBCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 3.16 indicates that RBCN has no problem at all paying its short term obligations.
With a Current ratio value of 3.16, RBCN perfoms like the industry average, outperforming 52.83% of the companies in the same industry.
A Quick Ratio of 2.37 indicates that RBCN has no problem at all paying its short term obligations.
RBCN has a Quick ratio of 2.37. This is comparable to the rest of the industry: RBCN outperforms 53.77% of its industry peers.
Industry RankSector Rank
Current Ratio 3.16
Quick Ratio 2.37
RBCN Yearly Current Assets VS Current LiabilitesRBCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

RBCN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 167.66%, which is quite impressive.
RBCN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.72%.
Measured over the past years, RBCN shows a very negative growth in Revenue. The Revenue has been decreasing by -27.01% on average per year.
EPS 1Y (TTM)167.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-346.56%
Revenue 1Y (TTM)2.72%
Revenue growth 3Y1.36%
Revenue growth 5Y-27.01%
Sales Q2Q%-46.93%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RBCN Yearly Revenue VS EstimatesRBCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M
RBCN Yearly EPS VS EstimatesRBCN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 -5 -10 -15 -20

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 3.94, the valuation of RBCN can be described as very cheap.
RBCN's Price/Earnings ratio is rather cheap when compared to the industry. RBCN is cheaper than 98.11% of the companies in the same industry.
When comparing the Price/Earnings ratio of RBCN to the average of the S&P500 Index (26.68), we can say RBCN is valued rather cheaply.
Industry RankSector Rank
PE 3.94
Fwd PE N/A
RBCN Price Earnings VS Forward Price EarningsRBCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RBCN Per share dataRBCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RBCN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RUBICON TECHNOLOGY INC

NASDAQ:RBCN (12/29/2022, 8:00:02 PM)

After market: 1.3 0 (0%)

1.3

-0.02 (-1.52%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)03-23 2023-03-23
Inst Owners0.01%
Inst Owner Change0%
Ins Owners531.39%
Ins Owner Change0%
Market Cap3.20M
Analysts43.33
Price TargetN/A
Short Float %0.46%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.94
Fwd PE N/A
P/S 0.82
P/FCF N/A
P/OCF N/A
P/B 1.06
P/tB 1.07
EV/EBITDA N/A
EPS(TTM)0.33
EY25.38%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS1.58
BVpS1.22
TBVpS1.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 15.17%
ROE 26.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 20.86%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.16
Quick Ratio 2.37
Altman-Z -85.4
F-Score5
WACC11.23%
ROIC/WACCN/A
Cap/Depr(3y)11.76%
Cap/Depr(5y)133.73%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)167.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-346.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.72%
Revenue growth 3Y1.36%
Revenue growth 5Y-27.01%
Sales Q2Q%-46.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y62.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y66.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.48%
OCF growth 3YN/A
OCF growth 5YN/A